1. Whole brain 3D MR fingerprinting in multiple sclerosis: a pilot study
- Author
-
Thomaz R. Mostardeiro, Ananya Panda, Norbert G. Campeau, Robert J. Witte, Nicholas B. Larson, Yi Sui, Aiming Lu, and Kiaran P. McGee
- Subjects
MR Fingerprinting ,Multiple Sclerosis ,Relaxometry ,Normal appearing white matter ,Splenium ,Medical technology ,R855-855.5 - Abstract
Abstract Background MR fingerprinting (MRF) is a novel imaging method proposed for the diagnosis of Multiple Sclerosis (MS). This study aims to determine if MR Fingerprinting (MRF) relaxometry can differentiate frontal normal appearing white matter (F-NAWM) and splenium in patients diagnosed with MS as compared to controls and to characterize the relaxometry of demyelinating plaques relative to the time of diagnosis. Methods Three-dimensional (3D) MRF data were acquired on a 3.0T MRI system resulting in isotropic voxels (1 × 1 × 1 mm3) and a total acquisition time of 4 min 38 s. Data were collected on 18 subjects paired with 18 controls. Regions of interest were drawn over MRF-derived T1 relaxometry maps encompassing selected MS lesions, F-NAWM and splenium. T1 and T2 relaxometry features from those segmented areas were used to classify MS lesions from F-NAWM and splenium with T-distributed stochastic neighbor embedding algorithms. Partial least squares discriminant analysis was performed to discriminate NAWM and Splenium in MS compared with controls. Results Mean out-of-fold machine learning prediction accuracy for discriminant results between MS patients and controls for F-NAWM was 65 % (p = 0.21) and approached 90 % (p
- Published
- 2021
- Full Text
- View/download PDF